| Unique ID issued by UMIN | UMIN000001529 |
|---|---|
| Receipt number | R000001846 |
| Scientific Title | Phase II trial of irinotecan plus cisplatin for pretreated patients with Ewing sarcoma and PNET |
| Date of disclosure of the study information | 2008/12/01 |
| Last modified on | 2018/12/13 12:25:58 |
Phase II trial of irinotecan plus cisplatin for pretreated patients with Ewing sarcoma and PNET
EFT-CPT-CDDP
Phase II trial of irinotecan plus cisplatin for pretreated patients with Ewing sarcoma and PNET
EFT-CPT-CDDP
| Japan |
pretreated Ewing sarcoma or PNET
| Hematology and clinical oncology |
Malignancy
NO
Efficacy
Safety
Response rate
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
| Medicine |
chemotherapy
| 18 | years-old | <= |
| Not applicable |
Male and Female
1)Ewing sarcoma or PNET
2)Advanced, metastatic or recurrent case
3)Prior treated with anthracycline agents and ifomaide
4)At least one target lesion
1)Patient who have no indication for chemotherapy
32
| 1st name | |
| Middle name | |
| Last name | Akira Kawai |
National cancer center hospital
Orthopedic surgery
5-1-1 Tsukiji, Chuo-ku, Tokyo
03-3542-2511
akawai@ncc.go.jp
| 1st name | |
| Middle name | |
| Last name | Kan Yonemori |
National cancer center hospital
Breast and Medical Oncology
Tsukji 5-1-1 Chuo-ku Tokyo, Japan
03-3542-2511
kyonemor@ncc.go.jp
National cancer center hospital
None
Self funding
NO
| 2008 | Year | 12 | Month | 01 | Day |
Unpublished
Completed
| 2006 | Year | 03 | Month | 31 | Day |
| 2006 | Year | 07 | Month | 01 | Day |
| 2012 | Year | 07 | Month | 01 | Day |
| 2008 | Year | 11 | Month | 26 | Day |
| 2018 | Year | 12 | Month | 13 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000001846